While most studies have demonstrated <50% PD-L1 expression in cases of SCLC, the majority of PD-L1 expression in these SCLC cases occurs on the infiltrating immune cells rather than the tumor cells themselves. The gene discussed is CD274; the disease is small cell lung carcinoma.